RENGER JOHN (Chief Scientific Officer) reported 1 transaction at CEREVEL THERAPEUTICS HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/5/2024ACC: 0000950170-24-090830
Officer· Chief Scientific Officer
Since Oct 2020
-887.42K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
887.42K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.37K
Price / share
—
Trade value
—
% of position
New position
8/1/2024
6.37K→0.00
Total
Net shares
−6.37K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2024 | D · Disposition | −6.37K | — | — | New position | 6.37K | 0.00 |
| Total | −6.37K | $0.00 | ||||||
Derivative Transactions3
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
778.42K shares
Shares
−778.42K
Strike price
Held after
0.00
Exercisable
—
8/1/2024
Restricted Stock Units
Direct
Converts to
Common Stock
15.06K shares
Shares
−15.06K
Strike price
Held after
0.00
Exercisable
—
8/1/2024
Restricted Stock Units
Direct
Converts to
Common Stock
87.57K shares
Shares
−87.57K
Strike price
Held after
0.00
Exercisable
—
8/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock778.42K shares | 8/1/2024 | D · Disposition | −778.42K | — | 0.00 | |
| Restricted Stock Units Direct | Common Stock15.06K shares | 8/1/2024 | D · Disposition | −15.06K | — | 0.00 | |
| Restricted Stock Units Direct | Common Stock87.57K shares | 8/1/2024 | D · Disposition | −87.57K | — | 0.00 |